1. The carrying amount of financial instruments measured at amortized costs (except for bank loans and bond) is a reasonable approximation of their fair value due to their short-term nature.
2. Receivables/payables arising from VAT/other non-income taxes and social security

In connection with the acquisition of Paramit, the Group entered into a deal contingent forward agreement to purchase USD 677 million and into a normal plain vanilla forward to purchase another USD 150 million (total USD 827 million, representing about 91% of the estimated purchase price without contingent consideration). The hedging agreements had matured at the day of the closing of the acquisition (after the balance sheet date on August 2, 2021). At that day the purchase price in USD was transferred to the seller and a bridge loan in CHF was granted by a bank to the Group until the final financing structure of the transaction would have been ready. 

As the targeted transaction was considered as highly probable at June 30, 2021 and all other conditions were met, the Group applied cash flow hedge accounting. The proportion of the gain or loss on the hedging instrument that was determined to be effective was recognized in other comprehensive income and allocated to the cash flow hedge reserve. The ineffective part of the cash flow hedge (mainly the contingent charge of the deal contingent forward) amounted to CHF 1.5 million and was reported in finance cost.